Gastrointestinal (GI) conditions are common in neonates and infants. These may include Gastroesophageal Reflux (GER), ...
Experiments in three therapeutic cancer vaccine mouse models, conducted by investigators at the Vaccine Branch of the National Cancer Institute in Bethesda, Maryland, support the conclusion that ...
Results, presented at ObesityWeek® 2025, showed patients receiving NG101 saw 40% reduction in nausea incidence and 67% ...
Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...
Sean Virani, MD, lead author of the new guidelines and president of the CCS, explained that the guidelines use the term ...
Researchers at Okayama University of Science have discovered that bitter taste receptors—the same type found on the human ...
A research team from the Department of Bioscience, Faculty of Life Sciences, Okayama University of Science, has made a discovery: bitter taste receptors are present inside cancer cells and play a ...
Even though nearly all women—approximately 85%—report experiencing menopause symptoms, science has offered very few solutions ...
Sparsentan therapy was associated with sustained decline in proteinuria and lower likelihood of progression to kidney failure ...
Type 1 diabetes with CKD is understudied with no advancement of therapy options since the 1990s. The FINE-ONE phase 3 trial addresses a high, unmet need for treatments.
The gastroparesis market is poised for significant growth, driven by the emergence of novel therapeutic classes such as the Dopamine D2 receptor antagonist (GIMOTI). Meanwhile, novel therapies like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback